Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
“COTA was founded in 2011 by oncologists, engineers, and data scientists, with one aim in mind: to transform cancer care so that every patient gets the right treatment. That’s not a mission we can achieve alone. We are committed to working with providers, payers, life sciences companies, patients and the FDA to change how cancer is studied and treated.”
Andrew Pecora, M.D. Founder & Chairman
Beyond Drug Prices: Understanding The True Cost of Treatment with Dr. Rafael Fonseca
In this episode of Real World Talk, host Kevin Keogh talks to Dr. Rafael Fonseca, a hematologist who specializes in multiple myeloma, and Interim Director of the Mayo Clinic’s Cancer Center.
They discuss the gulf between the idealized world of clinical trials and the reality experienced by patients with an incurable cancer like multiple myeloma — and how real world data can help bridge the gap.